Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Co    BMY

News SummaryMost relevantAll newsSector news 

Bristol-Myers Gets SEC Subpoena In Foreign Bribery Probe

04/26/2012 | 01:01pm US/Eastern
   By Peter Loftus 

Drug maker Bristol-Myers Squibb Co. (>> Bristol Myers Squibb Co.) said it has received a subpoena from the U.S. Securities and Exchange Commission as part of an investigation into bribery overseas.

Bristol-Myers said the subpoena received in March seeks information related to sales and marketing practices in "various countries."

The New York-based company said in a quarterly report filed Thursday with the SEC that it was cooperating with the government. A spokeswoman declined comment beyond the information in Thursday's SEC filing.

Bristol-Myers, which sells the anti-clotting drug Plavix, previously disclosed that the SEC was investigating the activities of the company's units in Germany, concerning potential violations of the U.S. Foreign Corrupt Practices Act, or FCPA.

U.S. authorities in recent years have stepped up enforcement of the FCPA, which bars U.S. companies from bribing foreign officials to obtain or retain business. Multinational drug and medical-device makers based in the U.S. have been among the targets of enforcement.

Last year, Johnson & Johnson (>> Johnson & Johnson) agreed to pay nearly $80 million to resolve allegations that it paid bribes to doctors in three European countries, as well as kickbacks to Iraq to illegally obtain business under former leader Saddam Hussein.

Other drug makers--including Pfizer Inc. (>> Pfizer Inc.), Merck & Co. (>> Merck & Co., Inc.) and Eli Lilly & Co. (>> Eli Lilly & Co.)--also have been the subjects of federal inquiries regarding the FCPA.

-By Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

React to this article
11/25 BRISTOL MYERS SQUIBB : New Long-Term Data on Opdivo and the Opdivo + Yervoy Regi..
11/25 BRISTOL MYERS SQUIBB : Study Results from Bristol-Myers Squibb Broaden Understan..
11/25 BRISTOL MYERS SQUIBB : An Application for the Trademark "NURSE PARTNERS EDUCATE/..
11/25 BRISTOL MYERS SQUIBB : Studies Conducted at Bristol-Myers Squibb on Cancer Thera..
11/25 BRISTOL MYERS SQUIBB : Patent Issued for Immunoconjugates, Compositions for Maki..
11/25 BRISTOL MYERS SQUIBB : Data from ALLY-3+ Trial Investigating Daklinza daclatasvi..
11/25 BRISTOL MYERS SQUIBB : New Type 2 Diabetes Study Findings Have Been Reported by ..
11/24 BRISTOL MYERS SQUIBB : FDA approves Bristol-Myers drug for advanced skin cancer
11/24 BRISTOL MYERS SQUIBB : European Commission Approves Reconciliation of Indication..
11/24 BRISTOL MYERS SQUIBB : Announces U.S. Food and Drug Administration Approval for ..
News chart
Full-screen chart
Income Statement Evolution
More Financials